WORK ORDER AGREEMENT
Exhibit 10.39.2
Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed. [***] indicates that information has been redacted.
between
Ares Genetics GmbH
Xxxx-Xxxxxx-Xxxxx 00
0000 Xxxx
Xxxxxxx
(the “Service Provider/Institution”)
and
Sandoz Xxxxxxxxxxxxx XxxX
Xxxxxxxxxxxxxxxx
00000 Xxxxxxxxxxx , Xxxxxxx
(“Sandoz”)
This work order (“Work Order”) shall be effective as of the Effective Date below. It is subject to the terms of the Services Frame Agreement (“Agreement”) between Sandoz and Service Provider/Institution dated 14 December zoi8.
1. | CONTRACT RESEARCH-RELATED INFORMATION. |
Effective Date: | 14. December 2018 |
Test Compound and Study No.: | IDEntifying the Optimal Use of existing and novel Antibiotics using a Digital Anti-Infectives Platform (IDEA) – Platform development and proof of concept based on [***], [***] and [***]. |
Expected Services Completion Date | 13. December 2019 |
Total Contract Value | $[***] |
Services Frame Agreement expiry date | 13.December 2021 |
1 |
Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed. [***] indicates that information has been redacted.
|
2. | RESPONSIBILITIES OF SERVICE PROVIDER/INSTITUTION |
Sandoz and the Service Provider/Institution agree that the Service Provider/Institution, either exclusively or jointly with Sandoz or its Affiliates or its authorised agent(s), shall have the responsibilities and shall perform the tasks as specified in the Study Specifications attached hereto as Schedule C and incorporated herein by reference and other documents which are attached hereto or incorporated by reference.
Subcontracting by the Service Provider/Institution in the performance of the Services and the performance of the Services by the subcontractors shall be bound by the terms`and conditions of the Agreement. Subcontractors used in the performance of the Services described herein are detailed in Schedule D.
3. | NOTICE |
Any notice required or permitted hereunder shall be in writing and shall be deemed given as of the date if it is (A) delivered by hand or (B) sent by registered or certified mail, postage prepaid, return receipt request, and addressed to the party to receive such notice at the address set forth below, or such other address as is subsequently specified in writing, as well as any persons so designated under the Agreement itself:
If to Sandoz:
Invoicing and Payments Matters: | Billing address: Salutas Pharma GmbH Zentrale Kreditorenbuchhaltung Xxxx-xxx-Xxxxxxxx-Xxxxx 0 00000 Xxxxxxxx Xxxxxxx |
Administrative / Contractual Matters: | Novartis Business Services City Green Court Xxxxxxxx 0000/0x 000 00, Xxxxx 0 Xxxxx Xxxxxxxx FAO Nina Sedlakova [***] |
Technical Matters: | Xxxxxxxx Xxxxxxxx Xxxxxxxxxxxx. 00 X-00000 Xxxxxxxxxxx Xxxxxxx |
2 |
Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed. [***] indicates that information has been redacted.
|
If to Service Provider/Institution:
Technical Matters: | Ares Genetics GmbH Xxxx-Xxxxxx Xxxxx 0000 Xxxx Xxxxxxx Attn: Business Development [***] |
Contract / Payment Matters: | Ares Genetics GmbH Xxxx-Xxxxxx Xxxxx 0000 Xxxx Xxxxxxx Attn: Business Development [***] |
4. | MODIFICATIONS AND ADDITIONAL TERMS FOR THIS CONTRACT SERVICES: |
N/A
5. | LIST OF ATTACHMENTS: |
· | Budget and Payment Schedule (Schedule A) |
· | Study Specification Worksheet (Schedule B) |
· | Subcontractors (Schedule C) |
· | Service Provider/Institution Proposal and Budget (Schedule D) |
6. | COST AND PAYMENT |
Payment shall be made to the Service Provider/Institution according to Schedule A appended hereto and incorporated herein by reference. All costs outlined on Schedule A shall remain firm for the duration of the Services, unless otherwise agreed to in writing by the Service Provider/Institution and Sandoz.
In Witness Whereof, the parties hereto have executed this Work Order in duplicate by proper persons thereunto duly authorised
- Signatures next page –
3 |
Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed. [***] indicates that information has been redacted.
|
SANDOZ INTERNATIONAL, GMBH | ARES GENETICS GMBH | |
By: /s/ NG Warwick Name: NG Warwick Title: Chief Medical Officer Date: 17 December 2018 |
By: Xxxxxxx Xxxxx Name: Xx. Xxxxxxx Xxxxx Title: Managing Director & CEO Date: 14 December 2018 | |
By: /s/ Xxxxxxxx Xxxxxx Name: Xxxxxxxx Xxxxxx Title: Head HRGI Product Development Functions Date: 17 December 2018 |
By: /s/ Achim Plum Name: Xx. Xxxxx Xxxx Title: Managing Director Date: 14 December 2018 |
4 |
Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed. [***] indicates that information has been redacted.
|
Schedule A
BUDGET AND PAYMENT SCHEDULE
[***]
5 |
Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed. [***] indicates that information has been redacted.
|
Schedule B
STUDY SPECIFICATIONS
[***]
6 |
Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed. [***] indicates that information has been redacted.
|
Schedule C
Subcontractors
Subcontractors to Service Provider/Institution in the performance of the Services described herein.
[***]
7 |
Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed. [***] indicates that information has been redacted.
|
Schedule D
Service Provider/Institution Proposal and Budget
[***]
8 |
Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed. [***] indicates that information has been redacted.
|
Work Plan
[***]
Budget
[***]
9 |
|